Spots Global Cancer Trial Database for dc vaccine
Every month we try and update this database with for dc vaccine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia | NCT05000801 | Acute Myeloid L... | DC vaccine | 18 Years - 70 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | NCT02808416 | Brain Cancer Neoplasm Metast... | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission | NCT01686334 | Acute Myeloid L... | DC vaccine | 18 Years - | University Hospital, Antwerp | |
| Personalized DC Vaccine for Lung Cancer | NCT02956551 | Carcinoma, Non-... | DC vaccine | 18 Years - 90 Years | Sichuan University | |
| A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence | NCT02334735 | Melanoma | DC Vaccine Montanide Vacci... Poly-ICLC | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| DC Vaccination in CML | NCT02543749 | Myeloid Leukemi... | DC vaccine | 18 Years - 80 Years | Charite University, Berlin, Germany | |
| Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) | NCT02709616 | Glioblastoma | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma | NCT00978913 | Breast Cancer Malignant Melan... | DC vaccine | 18 Years - | Herlev Hospital | |
| Tumor Vaccines for Solid Tumors | NCT06102837 | Glioma Solid Tumor | tumor vaccine Radiotherapy Chemotherapy Surgery | - | Huashan Hospital | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome | NCT04999943 | Myelodysplastic... Dendritic Cell Hypomethylating... Immunotherapy | DC vaccine | 60 Years - | Affiliated Hospital to Academy of Military Medical Sciences | |
| Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma | NCT04888611 | Recurrent Gliob... | Camrelizumab pl... Camrelizumab pl... | 18 Years - 70 Years | Huashan Hospital | |
| Dendritic Cell (DC) Vaccine for Malignant Glioma and Glioblastoma | NCT01808820 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... High Grade Glio... | Dendritic Cell ... Tumor Lysate Imiquimod Leukapheresis | 13 Years - 99 Years | University of Miami | |
| Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia | NCT05000801 | Acute Myeloid L... | DC vaccine | 18 Years - 70 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| DC1s-CTL Cellular Therapy for Renal Cell Carcinoma | NCT02787915 | Renal Cell Carc... | DC1-CTL | 18 Years - 80 Years | Xuzhou Medical University | |
| Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells | NCT00327496 | Carcinoma, Hepa... | DC vaccine | 30 Years - 80 Years | Mackay Memorial Hospital | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients | NCT00913913 | Metastatic Rena... | DC vaccine Bevacizumab IL-2 IFN | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| Dendritic Cell Based Therapy for Breast Cancer Patients | NCT00935558 | Breast Cancer | DC vaccine aromatase inhib... | 18 Years - | Herlev Hospital | |
| Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients | NCT00913913 | Metastatic Rena... | DC vaccine Bevacizumab IL-2 IFN | 18 Years - | Dartmouth-Hitchcock Medical Center | |
| DC Vaccine in Colorectal Cancer | NCT03730948 | Colorectal Canc... | DC vaccine | 18 Years - | University of Pennsylvania | |
| Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid Leukemia | NCT05000801 | Acute Myeloid L... | DC vaccine | 18 Years - 70 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI) | NCT01671592 | Colorectal Neop... Colorectal Canc... Colorectal Carc... Colorectal Tumo... Neoplasms, Colo... | DC Vaccine | 18 Years - | University of Pittsburgh | |
| Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma | NCT04888611 | Recurrent Gliob... | Camrelizumab pl... Camrelizumab pl... | 18 Years - 70 Years | Huashan Hospital | |
| DC Vaccination in CML | NCT02543749 | Myeloid Leukemi... | DC vaccine | 18 Years - 80 Years | Charite University, Berlin, Germany | |
| DC Vaccine in Colorectal Cancer | NCT03730948 | Colorectal Canc... | DC vaccine | 18 Years - | University of Pennsylvania | |
| Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome | NCT04999943 | Myelodysplastic... Dendritic Cell Hypomethylating... Immunotherapy | DC vaccine | 60 Years - | Affiliated Hospital to Academy of Military Medical Sciences | |
| Efficacy Study of Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia in Remission | NCT01686334 | Acute Myeloid L... | DC vaccine | 18 Years - | University Hospital, Antwerp | |
| Engineered Dendritic Cell Vaccines for Multiple Myeloma | NCT06435910 | Multiple Myelom... | DC vaccines | 18 Years - 80 Years | Shenzhen Geno-Immune Medical Institute | |
| Personalized Cellular Vaccine for Glioblastoma (PERCELLVAC) | NCT02709616 | Glioblastoma | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Personalized Cellular Vaccine for Brain Metastases (PERCELLVAC3) | NCT02808416 | Brain Cancer Neoplasm Metast... | Personalized ce... | 18 Years - 65 Years | Guangdong 999 Brain Hospital | |
| Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells | NCT00327496 | Carcinoma, Hepa... | DC vaccine | 30 Years - 80 Years | Mackay Memorial Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
